MOTS-c: What the Research Shows About This Mitochondrial Peptide
MOTS-c is a 16-amino-acid peptide that your mitochondria make naturally. In mice, injected MOTS-c has improved insulin sensitivity, reduced diet-induced weight gain, and boosted exercise capacity. In people, the best-documented finding is that your own MOTS-c levels rise during exercise. There is no good evidence yet that taking MOTS-c as a drug helps healthy people or patients, it is not approved anywhere as a medicine, and it is banned in tested sport.
Key takeaways
- MOTS-c is encoded in mitochondrial DNA and acts like a hormone-like signal, not just a cellular byproduct.
- Most evidence comes from mice and cell experiments. Human data are limited to small studies of natural levels and one early trial of a modified analog.
- A natural rise during exercise does not show that injecting the peptide produces the same benefits.
- US regulators reviewed MOTS-c in July 2026 and their own staff found no human clinical studies for the proposed uses.
- Exercise remains the proven way to improve insulin sensitivity and metabolic health.
What MOTS-c is and where it came from
Researchers at the University of Southern California described MOTS-c in 2015 in Cell Metabolism. They found a short open reading frame inside the mitochondrial 12S rRNA gene that encodes a 16-amino-acid peptide, which they named MOTS-c (Lee et al., 2015). That was surprising because mitochondrial DNA was thought mainly to code for parts of the energy-producing machinery. MOTS-c suggested mitochondria also send signals to the rest of the body.
What it appears to do
In the original mouse work, MOTS-c treatment prevented age-dependent and high-fat-diet-induced insulin resistance and diet-induced obesity (Lee et al., 2015). The proposed mechanism involves AMPK, an enzyme that senses low cellular energy and shifts cells toward using glucose and fat; MOTS-c is reported to activate it partly by altering folate and purine metabolism. A later study reported that MOTS-c improved physical performance in young, middle-aged, and old mice, including late-life treatment, and regulated skeletal muscle metabolism and gene expression (Reynolds et al., 2021).
These are controlled experiments in animals, usually with injected doses, and mice often respond differently from humans.
MOTS-c and exercise: what the human data say
The Reynolds study also measured MOTS-c in 10 healthy, sedentary young men who cycled once. Muscle MOTS-c rose nearly 12-fold after exercise and stayed partly elevated four hours later, while blood levels rose about 50% and returned to baseline after rest (USC summary). That is where the "exercise mimetic" label comes from.
The limits matter. The sample was small and all male. It shows MOTS-c responds to exercise, not that giving extra MOTS-c improves performance, recovery, or muscle growth in people. No published human trial demonstrates those effects.
The practical takeaway: if you want to improve insulin sensitivity, body composition, or mitochondrial fitness, regular aerobic and resistance training is the proven route, and it triggers your body's own MOTS-c along with many other adaptations.
Evidence by type
| Evidence type | What was found | What it cannot tell us |
|---|---|---|
| Mouse and cell studies | Improved insulin sensitivity, less diet-induced obesity, better physical performance | Whether people respond the same way, or at what safe dose |
| Small human exercise study (n = 10) | Natural MOTS-c rises with exercise | Whether supplementing helps |
| Early trial of a MOTS-c analog | See below | Effects of MOTS-c itself; long-term safety |
The one human drug trial involves an analog, not MOTS-c
The company CohBar tested CB4211, a modified analog of MOTS-c, in a randomized, placebo-controlled Phase 1a/1b trial for fatty liver disease and obesity. The company reported that it met its safety and tolerability goals and that treated participants had statistically significant reductions in liver enzymes (ALT, AST) and glucose after 4 weeks compared with placebo (CohBar press release). These are company-reported results from a short early-phase study of a different molecule, and the company's own risk disclosures noted injection-site reactions as a concern. They do not show that MOTS-c works for liver disease, diabetes, or weight loss.
Weight loss, diabetes, and anti-aging claims
Online marketing often presents MOTS-c as a weight-loss or longevity compound. The evidence does not support that for people. The weight and glucose effects come from mice, and aging claims rest on animal healthspan studies and the observation that levels change with age. Treat any product promising these results as unsupported.
Safety, legal status, and sport
Regulatory status changes quickly; this section reflects information available in October 2026, so check with your national regulator.
- Not an approved medicine. The US FDA has not approved MOTS-c. In 2023 FDA placed 19 peptides, including MOTS-c, in a category flagging significant safety concerns for pharmacy compounding (Health Affairs).
- July 2026 advisory committee. FDA's Pharmacy Compounding Advisory Committee met on July 23 and 24, 2026 to consider seven peptides including MOTS-c. FDA staff reported no human clinical studies of MOTS-c for the proposed uses (FDA briefing document), and trade press reported the panel nonetheless backed compounding for several peptides (Medscape). An advisory vote is a recommendation, not a final decision or an approval, and I could not confirm a final FDA ruling.
- Product quality. FDA's briefing flagged impurity and immunogenicity concerns for synthetic peptides. "Research use only" products sold online are not made under pharmaceutical quality controls.
- Banned in sport. MOTS-c is prohibited at all times under the World Anti-Doping Agency's list as an AMPK activator (USADA).
If you have diabetes, obesity, or another metabolic condition, evidence-based treatments exist and should not be replaced by an experimental peptide. Talk to a clinician about options.
FAQ
Is MOTS-c the same as exercise in a vial?
No. Exercise raises your natural MOTS-c, but it also changes many other signals and tissues. No human study shows that injected MOTS-c reproduces exercise benefits.
Does MOTS-c cause weight loss in humans?
There is no evidence that it does. Weight effects were observed in mice fed a high-fat diet.
Is MOTS-c safe?
Its long-term safety in people is unknown. The only human drug trial involved a modified analog, and unregulated products add contamination and purity risks.
Is MOTS-c legal?
It is not approved as a medicine. Rules on compounding and sale differ by country and are changing, so check your regulator. It is banned for athletes subject to anti-doping testing.
Can I raise my MOTS-c naturally?
Exercise raises it temporarily, as shown in a small study of young men. Regular training is also supported by far stronger evidence for metabolic health than any peptide.
This article is general education about research, not medical advice or a recommendation to use any substance.
